Abstract
Azacitidine, Homoharringtonine and Cytarabine Combined with Granulocyte Colony-Stimulating Factor As Frontline Treatment for Older Patients with Acute Myeloid Leukemia: A Prospective, Multicenter, Single-Arm Phase III Study in China
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have